Intravitreal triamcinolone with transpupillary therapy for subfoveal choroidal neovascularization in age related macular degeneration. A randomized controlled pilot study [ISRCTN74123635]期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Intravitreal triamcinolone with transpupillary therapy for subfoveal choroidal neovascularization in age related macular degeneration. A randomized controlled pilot study [ISRCTN74123635]

Authors:	Email author" target="_blank">Ricardo?Agurto-Rivera Email author Jose?Diaz-Rubio Luis?Torres-Bernal Tamer?A?Macky Juner?Colina-Luquez Gabriela?Papa-Oliva Rama?D?Jager Susana?Martinez-Jardon Jans?Fromow-Guerra Hugo?Quiroz-Mercado

Institution:	(1) Retina Service, Asociacin Para Evitar la Ceguera (APEC), Mexico City, Mexico;(2) Department of Ophthalmology, Kasr El Aini Hospital, Cairo University, Cairo, Egypt;(3) Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA

Abstract:	Background To assess the effect of intravitreal triamcinolone acetonide (iTA) as an adjunctive treatment to transpupillary therapy (TTT) for new subfoveal choroidal neovascular membranes (CNV) in age-related macular degeneration (AMD).

Keywords:
本文献已被 SpringerLink 等数据库收录！